Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    NCT03441113
Previous Study | Return to List | Next Study

Extended Access of Momelotinib in Adults With Myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03441113
Recruitment Status : Enrolling by invitation
First Posted : February 22, 2018
Last Update Posted : June 10, 2022
Information provided by (Responsible Party):
Sierra Oncology, Inc.

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : December 2026
Estimated Study Completion Date : December 2026